(Q38032198)

27 August 2017

title

Transformation in follicular lymphoma: biology, prognosis, and therapeutic options (English)

1 reference

27 August 2017

1 reference

Eric Wong

1 reference

27 August 2017

Michael Dickinson

series ordinal

1 reference

27 August 2017

publication date

1 October 2012

1 reference

27 August 2017

published in

Current Oncology Reports

1 reference

27 August 2017

1 reference

27 August 2017

1 reference

27 August 2017

page(s)

424-432

1 reference

Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Incidence, risk factors and outcome of histological transformation in follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Large-cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine-rituximab-containing regimens: natural history- or therapy-related complication?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

The follicular lymphoma microenvironment: From tumor cell to host immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Association ofHLA-DQB1alleles with risk of follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Reduced-intensity conditioning allogeneic stem cell transplant for relapsed or transformed aggressive B-cell non-Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0258-4

Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma.

21 January 2018

1 reference

12 December 2020

Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation

1 reference

12 December 2020

Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma

1 reference

12 December 2020

Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma

1 reference

12 December 2020

A 15-Year Analysis of Early and Late Autologous Hematopoietic Stem Cell Transplant in Relapsed, Aggressive, Transformed, and Nontransformed Follicular Lymphoma

1 reference

12 December 2020

Clonal evolution of B cells in transformation from low- to high-grade lymphoma

1 reference

12 December 2020

Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma

1 reference

12 December 2020

Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas

1 reference

12 December 2020

Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma

1 reference

12 December 2020

The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin

1 reference

12 December 2020

The natural history of initially untreated low-grade non-Hodgkin's lymphomas

1 reference

12 December 2020

10.1007/S11912-012-0258-4

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1040959010

0 references

Fatcat ID

release_v2dp4ai5w5du3mwx7a6llaaf2q

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v2dp4ai5w5du3mwx7a6llaaf2q

24 November 2022

mapped directly with Wikidata item

1 reference